Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential curative treatment for hematologic malignancies and non-malignant diseases. Because of the lower toxicity of reduced intensity conditioning, the number of transplants is in constant increase. However, allo-HSCT is still li...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamarthée, Baptiste, Malard, Florent, Saas, Philippe, Mohty, Mohamad, Gaugler, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836046/
https://www.ncbi.nlm.nih.gov/pubmed/27148267
http://dx.doi.org/10.3389/fimmu.2016.00148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836046/
https://www.ncbi.nlm.nih.gov/pubmed/27148267
http://dx.doi.org/10.3389/fimmu.2016.00148

Ejemplares similares